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Introduction 
 Officials in the National Hospice and Palliative Care Organization estimate that in 
2007, 1.4 million people received hospice services and 38.8% of  all deaths that occurred in 
the United States were under hospice care (NHPCO facts and figures: Hospice care in America, 
2008).  The concept of  hospice care was first implemented in the United States of  America 
in 1974 with the purpose of  providing terminally ill individuals with holistic, palliative care at 
the end of  their lives (Richman, 1995). This care is provided by a team of  nurses, home 
health aides, social service workers, chaplains, physicians, and volunteers (NHPCO facts and 
figures: Hospice care in America, 2008). An individual must have a terminal diagnosis (usually 
defined as being expected to live six months or less) and choose not to receive further 
curative treatments to enroll in hospice (Richman, 1995). Once enrolled, care may take place 
in a variety of  locations such as hospitals, nursing facilities, hospice facilities, or private 
homes. In 2007, 42% of  hospice deaths occurred in private residences, 28.3% in nursing or 
residential facilities, 19.2% in hospice inpatient facilities, and 10.5% in hospitals not operated 
by hospice organizations (NHPCO facts and figures: Hospice care in America, 2008). 
 Hospice services are aimed at increasing the quality of  life of  patients and include 
intensive pain management as well as physical, psychological, social, emotional, and spiritual 
care (Richman, 1995). In particular, the hospice team works to manage the patient's pain, 
including short-term inpatient care if  pain management needs become too extensive to treat 
at home; to help the patient to cope with the emotional, spiritual, and psychosocial aspects 
of  dying; to assist the family by teaching them how to care for the patient and by providing 
respite care when needed; to deliver medications, medical equipment and supplies, and 
special services (e.g., speech or physical therapy); and to provide bereavement care and 
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counseling to the family after the patient's death (NHPCO facts and figures: Hospice care in 
America, 2008). 
 As the number of  individuals under hospice care has grown, concerns about research 
with individuals at the end-of-life have become more prominent. As officials in the National 
Institutes of  Health [NIH] note, “While there is a growing body of  research covering a wide 
range of  issues, the research is, in many ways, still in its infancy in terms of  rigorous testing 
and evaluation of  models of  care, in terms of  patients and family outcomes, and in terms of  
resource utilization” (“Improving end-of-life care,” 2004). However, research with patients at 
the end-of-life is replete with potential ethical and logistical pitfalls and the literature in this 
area contains an abundance of  discussion on challenges which can be expected to arise when 
one is researching hospice and palliative care populations (Bruera, 1994; Buss & Arnold, 
2004; Casarett, Knebel, & Helmers, 2003; Dobratz, 2003; Fowell, Johnstone, Finlay, D. 
Russell, & I. T. Russell, 2006; Jordhøy et al., 1999; Kaasa, Hjermstad, & Loge, 2006; Penrod 
& Morrison, 2004). The implicit question embedded in this discussion is, “How can 
researchers best proceed in this difficult area?”. Unless and until this question is answered, 
the pace and quality of  this research is likely to suffer. The goal of  this thesis is to 
thoroughly and critically review the literature concerning the ethical and logistical challenges 
inherent in conducting research with hospice and palliative care patients which has arisen 
over the last twenty years and synthesize this information into a functional set of  guidelines 
to assist researchers in avoiding the possible pitfalls of  conducting research in this area. This 
literature review will cover the areas of  the ethicality of  either including or excluding hospice 
and palliative care populations; issues of  study design, informed consent, and recruitment; 
possible areas of  risk and benefit; and ethical and methodological issues. 
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 The following literature review was conducted with the search engines PsycInfo, 
Medline, and CINAHL. In PsycInfo, the terms “hospice”, “palliative care”, “experimental 
ethics”, “informed consent”, “methodology”, and “experimental subjects” were used. In 
Medline, the corresponding terms “hospices”, “palliative care”, “ethics, research”, “informed 
consent”, “research design”, and “research subjects” were included. To limit the amount of  
irrelevant information returned from the Medline search, “ethics, research” was used as a 
mandatory search term. In CINAHL, the corresponding terms “hospices”, “palliative care”, 
“ethics”, “consent”, “research methodology”, and “research subjects” were included. To 
limit the amount of  information returned from all searches and to provide relatively recent 
information, results were limited to sources published between the years 1990 through 2009. 
Although it was not included as a search limit, articles focusing on pediatric hospice were not 
included. The final main section includes the author's discussion of  the research question. 
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Literature Review 
Ethicality of  Including or Excluding this Population as Participants 
 There has been recent debate over whether it is ethical to include or exclude hospice 
and palliative care patients as research participants. Some researchers have argued that 
hospice and palliative care patients are too ill and too vulnerable to allow for valid and 
generalizable research, that there is not enough more to learn about this population to justify 
its use as research participants, and that this population is too heterogeneous to provide 
meaningful results (Kaasa & De Conno, 2001). Researchers have also expressed concern that 
it is unethical to ask hospice and palliative care patients to participate in research because 
participation may limit the already restricted time and energy these individuals have and 
because these participants will not have the opportunity to benefit from the results of  the 
research (Addington-Hall, 2002). 
 While these concerns are valid, the literature generated by this review was 
overwhelmingly in favor of  the ethicality of  including this population. Researchers have 
pointed out several reasons why it may be unethical to exclude this population. Researchers 
frequently mentioned respect for patients' autonomy as an opposing concern (Addington-
Hall, 2002; Bruera, 1994; Gysels, Shipman, & Higginson, 2008; Hudson, Aranda, 
Kristjanson, & Quinn, 2005; Kaasa & De Conno, 2001). By not offering hospice and 
palliative care patients the opportunity to participate in research, their right to make their 
own decisions about research participation and to have their voices heard is violated. Also, 
while this population will not likely benefit from the knowledge generated by the research, 
they may experience subjective benefits from their participation which would be unethical to 
deny (Gysels et al., 2008). These potential benefits will be discussed in greater detail in 
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subsequent sections. 
 Terry et al. (2006) argue that reservations about including hospice and palliative care 
patients as research participants are more a reflection of  the societal taboo against speaking 
about death and  dying than they are valid ethical concerns. In regard to a National Institutes 
of  Health consensus conference report which expressed concerns about the 'decency or 
propriety' of  asking these patients to participate in research, they rebutted: 
These feelings of  shame are, we suggest, those of  the researchers. This is the 
language of  taboo and we do not know of  any other area of  medical research that 
has, in recent years at least, provoked it. This is unfortunate because one reason to 
value the opportunity to participate in research commonly expressed by our patients 
was that it would confirm that they were still, and were regarded as, real people: not 
taboo (p. 412). 
Thus, while it is important to be aware of  the possible vulnerability of  this population, it is 
equally important to respect their rights of  autonomy and their humanity. 
Study Design 
 The complexities of  conducting research with hospice and palliative care populations 
are apparent from the first steps of  the research process. In order for the research to proceed 
smoothly, researchers must invest a great deal of  time creating an appropriate, thoughtful 
design. Areas of  study design that are particularly relevant to hospice and palliative care 
research are allowing adequate preparation time, identifying the target population, choosing 
an appropriate research design, determining the sample size, and including diversity for a 
representative sample. 
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Preparation Time 
 Because of  the complexities involved, research with hospice patients can be expected 
to be time consuming well before data collection begins (Seymour et al., 2005). Barnes et al. 
(2005) reported that almost one year was required to plan and obtain approval for a study on 
heart failure in older adults. Seymour et al. (2005) suggest that researchers take into account 
the time required to  identify and carry out specific training or educational needs and plan 
site visits to clarify access, researcher role, and ethical conduct when planning a timeline for 
research projects involving hospice or palliative care patients. 
Identifying the Target Population 
 Hospice and palliative care patients are a heterogeneous group, and an important, and 
sometimes problematic, part of  designing a study with this population is identifying a 
specific target population (Bakitas, Lyons, Dixon, & Ahles, 2006). While hospice services 
exclude patients who plan to continue with curative treatments and have more concrete 
guidelines regarding life expectancy, patients in palliative care services may span a wide range 
of  life expectancies and concurrent treatments. One third of  patients receiving palliative care 
services are not under the care of  palliative care specialists, meaning that using this as an 
inclusion criteria could exclude a large percentage of  palliative care patients who may differ 
in some way from those under the care of  specialists (Addington-Hall, 2002). As Jordhøy et 
al. (1999) point out, it may be impossible to identify every member of  a palliative care 
population in order to select an unbiased sample, especially as lengthy screening procedures 
are contraindicated for this population and are often not economically feasible. 
Research Design 
 Randomized controlled trials. While randomized controlled trials (RCTs) are needed in 
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palliative care and hospice research, they present several challenges which may make them 
difficult to implement (Penrod & Morrison, 2004; Storey, 2004). For instance, researchers 
may find that because many palliative care interventions are well established and believed to 
be efficacious despite the lack of  supporting empirical research, it may be considered 
unethical to withhold a standard treatment from the control group (Penrod & Morrison, 
2004). As Grande and Todd explain, “For a trial to be ethically justifiable there must be real 
uncertainty as to whether the new treatment is superior to no treatment, or existing 
treatments” (2000, p. 70).  This concept is known as 'equipoise'(Grande & Todd, 2000). 
However, even when equipoise exists, a new treatment may be perceived as more desirable by 
professionals, patients, and/or families(Grande & Todd, 2000). In this situation, wait list 
controls are a possible solution; however, the limited life expectancy of  palliative care and 
hospice patients limits the usefulness of  this strategy (Grande & Todd, 2000). Alternatively, 
researchers and care staff  may establish participation in the RCT as an entry point to the 
intervention, thus framings trial randomization as the offer of  an opportunity to access a 
currently unavailable treatment rather than as a means of  limiting the availability of  the 
treatment (Grande & Todd, 2000). Cluster randomization, in which potential participants are 
grouped by a common characteristic (e.g., region, hospice program, etc.) and are assigned to 
various experimental conditions, may be a more acceptable alternative because which groups 
will receive which treatments is established before the participants are identified (Fowell et 
al., 2006; Grande & Todd, 2000; Jordhøy et al., 1999). However, this may result in selection 
bias through the resentful demoralization of  patients selected for the control group and may 
reduce the statistical power of  the trial (Fowell et al., 2006). 
 A great deal of  discussion in recent literature has focused on placebo-controlled trials 
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in this population. The general consensus is that all research participants in clinical trials 
should have access to the best available standard of  care (Casarett, 2005; Ferrell, 2004). 
Casarett explains that placebo use can be justified if  the participants who receive the placebo 
also receive the current standard of  care, if  the symptom being studied has no effective 
treatment, or if  the participants who receive the placebo have access to breakthrough 
treatment should it becomes necessary (2005). Placebo-controlled trials require careful 
consideration of  the study design to ensure the placebo group does not receive substandard 
care, as well as additional time and effort in educating medical staff  and potential participants 
on this research methodology (Buss & Arnold, 2004). Terry et al. (2006) found that most 
palliative care patients were reluctant to participate in placebo-controlled trials. However, 
their reluctance was related to the assumption that researchers knew that the patients 
receiving the placebo would have worse outcomes than the patients receiving the treatment. 
It appears that trials comparing a new treatment to an established, active treatment are more 
likely to be acceptable to potential participants. 
 Qualitative research. Because of  the difficulties inherent in randomized controlled trials, 
qualitative approaches are popular among hospice and palliative care populations. Qualitative 
research frequently utilizes interviews, participant observation, questionnaires, focus groups, 
case studies, and documentary analysis (Wilkie, 1997), and qualitative methods are often 
preferred by end-of-life researchers because of  their ability to allow participants to discuss 
issues that are currently important to them (Kendall et al., 2007). Interview methods offer a 
particularly adaptive, flexible methodology for gaining information about hospice and 
palliative care patients and their experiences while also supporting the needs and well-being 
of  the participants (Plant, 1996). However, researchers must still be sensitive to possible 
 9 
ethical concerns in qualitative, as well as quantitative research; In particular, coercion and 
perceived benefit to participants are areas of  potential risk (Larkin, Casterle, & Schotsmans, 
2008). 
 A phenomenological paradigm (i.e., a qualitative approach which searches to 
understand how people make sense of  the everyday world) may be particularly applicable to 
palliative care research (Seymour & Clark, 1998). In phenomenological research, the 
researcher attempts to gather data in ways which are minimally intrusive to the participant 
and which maximize the participant's contribution to the research. Data collection is 
considered complete when no new material is generated by data collection, and cases which 
are atypical are emphasized rather than ignored. Seymour and Clark explain, 
“Phenomenology is not a method ... Rather it should be seen as a philosophical paradigm within 
which methods are chosen and questions framed” (1998, p. 128). 
 Case studies are also a qualitative approach which is frequently used in hospice and 
palliative care settings. Case studies can be an especially diverse approach. As Walshe, Caress, 
Chew-Graham, and Todd explain, “Case studies can use either qualitative or quantitative 
methods, can be prospective or retrospective, can have an inductive or deductive approach to 
theory, can focus on one case or many, can describe, explain or evaluate” (2004, p. 677) and 
are useful for studying “complex social situations or interventions, where multiple variables 
exist” (2004, p. 678). However, only qualitative case studies were discussed in the literature 
on hospice and palliative care research. Walshe et al. (2004) list several situations in which 
case studies are appropriate in palliative care research, including when complex situations 
need to be addressed, context is central to the study, multiple perspectives need to be 
recognized, the study design needs to be flexible, researchers want the research to be directly 
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congruent with a clinical practice approach, there is no strong theory to which to appeal, and 
other research methodologies could be difficult to conduct. However, they note that case 
studies must be used rigorously and only with appropriate reasoning for their use. 
 Focus groups allow for a group of  individuals to provide information collaboratively 
and may also be applicable to research with hospice and palliative care patients. However, 
some additional factors must be taken into consideration when using this approach. Seymour 
et al. (2005) describe how, in a focus group of  palliative care patients regarding end-of-life 
issues, researchers had to be careful to allow individual expression of  thoughts and opinions 
while still maintaining a clear structure around the topics they intended to discuss. 
Additionally, researchers had to be prepared to allow and create opportunities for 
participants to take a break from the discussion or to share their personal stories if  desired. 
 Mixed methods. Researchers can use mixed methods, which combine qualitative and 
quantitative methodologies, to collect and synthesize both types of  data (Wallen & Berger, 
2004). While little mixed methods research has been done in hospice and palliative care 
settings, it offers the potential to combine the benefits of  both procedures and offer an in-
depth set of  data for analysis. 
 Survey research. Surveys are frequently used in palliative care and hospice research (e.g., 
Takesaka, Crowley, & Casarett, 2004; C. J. Williams, Shuster, Clay, & Burgio, 2006). While 
surveys are most commonly completed by the patient, in some studies a proxy is used to 
obtain information regarding patients who may not be able to complete the surveys 
themselves. While this may be useful in some cases, it may also complicate the data collection 
process by raising the questions of  whether to approach the patient or the proxy first, when 
to approach the proxy (e.g., it would be inappropriate to contact the proxy when the patient 
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is rapidly declining), how to schedule data collection in a way that fits a caregiver's schedule, 
and how to determine who the proxy should be (Kapo & Casarett, 2004). However, it does 
offer an opportunity for retrospective survey research (i.e., research regarding the patient that 
occurs after the patient's death) as well as for collecting data on care at the time of  death and 
data from patients who were too ill to participate in direct data collection (Addington-Hall, 
2002; Kapo & Casarett, 2004). When conducting retrospective survey research using proxies, 
it is essential to consider the timing of  data collection, as collecting data too soon, when the 
proxy is not yet ready to discuss the deceased patient, or too late, when the proxy has 
forgotten important details, may both end with unsatisfactory results (Kapo & Casarett, 
2004). 
 Collaborative approaches. Collaborative approaches, which involve patients working as 
co-researchers with the investigators, have been suggested, and utilized, for research with 
hospice and palliative care populations (A. Williams et al., 2005; Wright, Hopkinson, Corner, 
& Foster, 2006). Collaborative approaches may be especially useful with this population as 
these methods are very sensitive to the needs of  the population and allow participants to 
influence the research in ways that result in study outcomes that are important to them 
(Wright et al., 2006). In one collaborative study, patients and caregivers volunteered as co-
researchers by leading focus groups of  hospice and palliative care patients (Wright et al., 
2006). Wright et al. (2006) suggested several recommendations for conducting research with 
co-researchers as a result of  this study, including being careful to apply the same ethical 
guidelines that apply to participations to co-researchers, offering emotional support for all 
co-researchers if  needed, and working to develop a collaborative dynamic in which the 
experienced researchers and co-researchers work together to ensure the quality of  the 
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research. 
 Williams et al. (2005) used a collaborative approach known as community-based 
participatory research (CBPR) to conduct research in a nursing facility for people with end-
stage AIDS. In CBPR, community members with strong ties to the research population, 
rather than members of  the research population itself, are included as co-researchers. In this 
study, staff  at the facility were included throughout the research process in order to create a 
participation opportunity that was feasible and relevant to the community. This method can 
be particularly useful in populations which are vulnerable and marginalized as it invites the 
opportunity for those close to the population to advocate for both the researchers and the 
participants in a manner that creates a beneficial research experience for all parties (A. 
Williams et al., 2005).  
Sample Size 
 Due to the high rates of  attrition that occur in hospice and palliative care research (a 
topic which will be discussed further in the 'Methodological Issues' section), researchers must 
take care to begin research with an adequate sample size to allow for attrition (Casarett, 
2005). Additionally, researchers should consider the proportion of  hospice and palliative care 
patients that will be excluded from the study due to inclusion/exclusion criteria. In a study by 
Williams et al. (2006), 64% of  hospice patients were ruled out by the criteria that stated 
participants must be over the age of  19, English speaking, judged able to give informed 
consent by either the investigator or a hospice nurse,  enrolled in hospice services for over a 
week, and not considered too sick (e.g., actively dying or in a crisis situation) to participate by 
the hospice nurse or physician. Researchers should be aware that many potential participants 
may decline to participate for a number of  reasons. For example, Williams et al. (2006) had a 
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return rate of  36% of  surveys which were distributed to hospice patients eligible to 
participate in their study. 
Diversity 
 Palliative care and hospice research often includes a paucity of  minority participants. 
For example, only 1 of  14 participants in a focus group study in South Africa was of  a 
minority ethnic background (Wright et al., 2006). Many researchers in a focus group study 
expressed concern that more efforts needed to be made to include diversity in hospice and 
palliative care research (Kendall et al., 2007). There are  many potential reasons for the lack 
of  diversity in this field of  research. As Kendall et al. (2007) state, “Given the recruitment 
difficulties within the majority population, it is not surprising that many studies fail to engage 
with people from these small populations” (p. 3). Language barriers and the fact that a lower 
proportion of  minority individuals than majority individuals seek palliative care services likely 
also play a role in this issue. However, there may be solutions to these problems. As the focus 
group of  researchers suggested, offering something (i.e., information sessions, art based 
activities, or social events) in return for participation, gaining approval from community 
leaders, and ensuring that the study design, research materials, and dissemination methods 
are culturally appropriate may serve to increase the amount of  minority patients who 
participate in hospice and palliative care research (Kendall et al., 2007). 
Summary 
 Researchers must be prepared to invest a great deal of  time in study design and data 
collection. The hospice and palliative care population is heterogeneous and complex, and 
researchers must consider carefully how to define their target population. Once this is 
decided, there are numerous research designs which are appropriate for use is this 
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population, including quantitative designs, randomized controlled designs, qualitative designs, 
phenomenological approaches, case studies, focus groups, mixed methods, survey designs, 
and collaborative approaches. For researchers to decide which method is best, they must 
carefully consider the research question as well as the benefits and disadvantages of  each 
methodology. Researchers must also work to obtain an adequate sample size and a good 
representation of  diversity in their sample. 
Informed Consent 
 As hospice and palliative care patients are considered members of  a vulnerable 
population, it is essential that potential participants are given adequate informed consent. 
Researchers must ensure that participation is voluntary and that potential participants are 
competent to give consent. Careful consideration should be given to the wording and 
method of  delivery of  consent. 
Vulnerability and Voluntariness 
 Many researchers consider hospice and palliative care populations to be vulnerable 
research participants (Casarett et al., 2003; Morreim, 2006). One reason for this is that 
patients at the end of  life may choose to participate out of  desperation (Casarett & 
Karlawish, 2000; Morreim, 2006) or loneliness (Seymour et al., 2005) rather than an 
informed choice(Casarett & Karlawish, 2000; Morreim, 2006). 
 Because of  this population's vulnerable status, it is extremely important to ensure 
that research participation is voluntary. It is necessary to understand how the patients' 
relationships with the investigators and the involved institution influence the decision to 
participate in order to ensure that patients are not, and do not feel, coerced into participating 
(Casarett et al., 2003; Silverman, 1996). Researchers must be aware that patients may feel 
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pressure to participate in research projects in order to please their doctor and must actively 
help patients realize both that it is alright for them to decline participation and that refusal 
will not affect their relationship with their doctor or other staff  (Casarett & Karlawish, 2000; 
Speck, 1996). Longer-term research carries additional challenges. Patients who are competent 
to consent at the time of  informed consent may deteriorate to the point where they are no 
longer competent to consent or understand changes in their condition that warrant their 
withdrawal (Casarett, 2005). Speck (1996) suggests that a friend or family member of  the 
patient be present at the time of  consent to ensure that there is no coercion. Similarly, 
Silverman (1996) suggests a neutral third party be present to advocate for the patient or 
proxy consenter, minimize coercion, and promote the participant and/or proxy consenter's 
understanding. 
 While it is important that researchers be aware of  issues of  coercion and 
voluntariness in informed consent, several researchers have presented evidence that patients 
are willing to refuse research participation. For instance, Rees and Hardy (2003) reported a 
refusal rate of  32% in their trial of  antimuscarinic drugs for treating the noisy breathing that 
occurs when dying patients are unable to clear secretions form their airways, often known as 
“death rattle”; 34 out of  107 palliative care patients approached declined to participate. Terry 
et al. (2006) reported that the palliative care patients who participated in their focus groups 
argued that “there is a 'freedom' in being close to death so that they felt they could say 
precisely what they wished and had nothing at all to lose by voicing their own opinion” (p. 
410). As one patient explained, “When you go to the emergency they ask you things, they 
don't think you have stopped thinking. Why would you not know what to say just because 
you are dying in the hospice [?]” (p. 410). In light of  concerns that patients may participate 
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out of  desperation to extend their lives, Terry et al. (2006) reported that the majority of  
participants stated they would only participate in research if  it did not have the possibility of  
extending their life.  
 As several researchers have pointed out, the potential for coercion in research with 
hospice and palliative care patients is not unique to this population and many strategies, such 
as emphasizing the voluntary nature of  participation and ensuring that researchers are 
sensitive to subtle forms of  pressure, may be used to overcome these challenges (Casarett & 
Karlawish, 2000; Fine, 2004). Fine argues that researchers should “not equate vulnerability 
with involuntariness” (p. 75) and that “dying should not be equated with coercion” (p. 75). 
Instead, both patients and research should be evaluated in light of  their context. 
Competence 
 Once vulnerability and voluntariness are addressed, researchers must establish that 
patients are competent to consent to participate in research. In terms of  informed consent, 
competence concerns “the ability to make a decision” (Silverman, 1996, p. 583). While it has 
no universally agreed upon definition, it is commonly noted to consist of  the capacity to 
understand information, to appreciate one's situation and its consequences, to consider 
information pragmatically in light of  one's values, and to make a decision (Silverman, 1996). 
Because this population is diverse with regard to the ability to make competent and informed 
decisions, patients must be individually evaluated for competence to give informed consent 
(Casarett, 2005; Casarett & Karlawish, 2000; Casarett et al., 2003; Dobratz, 2003; Fine, 2004). 
However, researchers should not assume palliative care and hospice patients are incapable of  
informed consent or that this is a rare phenomena. Gysels, Shipman, and Higginson (2008) 
noted that most of  the palliative care patients they interviewed were capable of  making the 
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decision to participate in an interview, as well as advocating for the conditions under which 
they wished to participate. Also, competence can fluctuate vastly over time, making it an 
ambiguous area to assess (Dobratz, 2003; Speck, 1996). Researchers must be aware that 
known cognitive impairment does not rule out decision making capacity. However, the 
presence of  cognitive impairment may make the process of  informed consent more difficult 
or impossible (Bakitas et al., 2006; Casarett & Karlawish, 2000). 
 When evaluating competence to consent, consideration must be given to the 
potential risks and benefits offered by the study (Addington-Hall, 2002; Casarett et al., 2003; 
Fine, 2004). Fine suggests that when minimal risks are posed by the study, a formal capacity 
assessment should not be required. When the study poses greater than minimal risks, Fine 
suggests, formal capacity assessment should be considered when potential benefits are 
offered and should be required when there are no potential benefits. Additionally, Fine 
recommends investigators use the MacArthur Competency Assessment Tool for Clinical 
Research (MacCAT-CR) for assessing competence to consent, and that investigators 
determine what the cut-off  point for competence will be before administering this 
assessment to potential participants. The Mini Mental Status Exam (MMSE) has also been 
commonly used in this field of  research (Bakitas et al., 2006; A. Williams et al., 2005)  as well 
as the Mini Mental Status Questionnaire (MMSQ, Bruera, 1994). Bruera (1994) has noted 
that patients should not be excluded from research due to incompletion of  the MMSQ. 
Nonetheless, researchers should be concerned that such participants may not be capable of  
completely understanding the study. One downfall of  the MMSQ is that it lacks specificity 
and may result in Type I error (Grealish, 2000). Many researchers have chosen to use 
informal assessment of  competence by a researcher or medical professional rather than a 
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formal assessment such as the MacCAT-CR, MMSE, or MMSQ (e.g., Dobratz, 2003; C. J. 
Williams et al., 2006). Despite the prevalence of  this option, it should be noted that one 
researcher who used these methods commented that use of  a formal assessment of  cognitive 
function would have been helpful in her study and recommended it for future use (Dobratz, 
2003). 
 Mental status is valuable as an inclusion/exclusion criteria for ensuring that 
competent consent is obtained, but it may result in issues with generalizability. Studies which 
only include patients who possess a normal mental status may not be generalizable to the 
palliative care and hospice population as a whole, in which patients are often sedated, 
delirious, or experiencing other declines in mental functioning (Bakitas et al., 2006). In light 
of  this possible complication, Bakitas et al. (2006) recommend that researchers consider 
whether a normal mental status is necessary for the patient to participate in and possibly 
benefit from the intervention or if  it is solely necessary for the research procedures (e.g., 
informed consent).  
Proxy Consent 
 If  patients are not competent to give consent, a legally authorized proxy may be able 
to consent on their behalf  (Bakitas et al., 2006; Casarett, 2005; Hardy, 2000). However, 'dual 
consent', in which both the participant and the proxy provide consent, is recommended to 
ensure that the participants receive as much information as possible even if  they cannot 
provide consent themselves (Casarett, 2005). Before using proxy consent in a study, 
researchers must first understand their state laws regarding proxy consent for research, as 
some states may restrict or prohibit proxy consent (Casarett, 2005). Also, researchers should 
be aware the process of  surrogate decision-making still needs further exploration and the 
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families of  palliative care and hospice patients may still comprise a vulnerable population as 
they may feel pressured to do everything they can to increase their loved ones' well-being or 
to extend their lives (Silverman, 1996). 
Process Consent 
 Process consent is one alternative to the traditional, one-time method of  obtaining 
informed consent. In process consent, the researcher regularly asks the participants if  they 
still wish to participate (Addington-Hall, 2002). Process consent is recommended when a 
study involves several interviews or observations over a period of  time (Kendall et al., 2007). 
It is designed to “acknowledge the dynamic and emerging nature of  the research design, 
include the initial input and suggestions of  the participants in the study, and negotiate further 
input regarding changes over time” (Raudonis, 1992, p. 247). Hudson, Aranda, Kristjanson, 
and Quinn (2005) caution against gathering informed consent at every data collection point 
due to the danger of  overloading the participant. Rather, they recommend that research staff  
remain constantly prepared to initiate discussion regarding consent, especially when they 
sense hesitance in the participant. 
Advance Consent 
 In situations where the potential participants will be unable to provide consent at the 
time they become eligible to participate, advance consent allows researchers to obtain 
consent to collect data if  they should develop target symptoms (Casarett, 2005; Casarett et 
al., 2003; Rees & Hardy, 2003). For example, in a trial of  antimuscarinic medications 
intended to treat the noisy breathing, or death rattle, that occurs at the end of  life, 
researchers asked patients if  they would be willing to participate should they develop noisy 
breathing at the end of  life, at which time they would not be expected to be able to provide 
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informed consent (Rees & Hardy, 2003). On each subsequent hospital admission, the 
participant was asked to re-sign the informed consent. If  they were no longer competent to 
consent, the patient's relative or caregiver was asked if  there was any reason the patient might 
have changed his or her mind about the decision to participate. If  no indication was stated, 
the previously signed consent was considered to remain valid. While advance consent is 
necessary for studies in which the participant is expected to lose capacity to consent or in 
which the capacity to consent is intermittent, it should be used only when necessary and 
should be obtained as close to the time of  expected study enrollment as is possible (Casarett, 
2005). Advance consent may be especially practical when the study poses greater than 
minimal risk and/or no potential benefits (Casarett, 2005). 
Cluster Consent 
 Another alternative method for obtaining informed consent is cluster consent, which 
involves obtaining consent from an entire group of  patients with a 'cluster guardian' 
responsible for providing consent as a proxy for the group and a 'cluster gatekeeper' 
responsible for advocating and taking responsibility for individual participants (Fowell et al., 
2006). Researchers comparing cluster consent with randomized consent methods found that 
cluster consent resulted in a larger number of   participants recruited and less burden for 
medical staff, as consent was given at a unit, rather than individual, level (Fowell et al., 2006). 
However, this method is not without disadvantages. Fowell et al. warn that cluster consent 
may be more likely to result in selection bias via the resentful demoralization of  control 
participants. Also, the randomization of  groups as opposed to individuals reduces statistical 
power. 
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Wording and Method of  Delivery 
 The wording and delivery of  informed consent can affect patient understanding and 
ability to provide consent. In order to lessen the risk of  physical fatigue, mental fatigue, or 
emotional distress in the patient or family, the consent form should be concise and simply 
worded and the patient or proxy should be given ample time to read the consent form fully 
and discuss it with other family members or medical staff  if  desired (Bruera, 1994; 
Silverman, 1996). 
 Researchers should also be aware that terms such as “palliative care”, “terminally ill”, 
and “end-of-life” may be detrimental to recruitment as not all patients have been given a 
clear, terminal prognosis by their doctors and may not identify as terminally ill or dying 
(Plant, 1996). While some researchers have expressed concern that avoiding such 
terminology may prevent potential participants from having all the information needed to 
provide informed consent (Barnes et al., 2005), others argue that this information is 
unnecessary and should not be considered deceptive (Casarett et al., 2003). Plant (1996) 
suggests researchers devote time to establishing understanding of  the potential participants' 
view of  their condition before attempting to obtain consent. Additionally, wording that 
suggests a doctor-patient relationship, such as “doctor”, “patient”, and “drug” as opposed to 
“investigator”, “subject”, and “study agent”, may suggest that patients are consenting to 
treatment rather than research (Silverman, 1996). Researchers should similarly avoid the use 
of  ambiguous expressions of  probability such as “likely”, “probable”, “expected”, or 
“moderate” (Silverman, 1996). 
 Terry et al. (2006) reported the palliative care patients in their sample strongly 
preferred oral information to written information. As one participant pointed out, “Do you 
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see anyone writing here? Reading things is so hard” (p. 411). However, Speck (1996) argues 
that potential participants should be given some form of  back-up information regarding 
consent, such as leaflets, videos, or information sheets, because adjustment to a terminal 
diagnosis may result in poor information retention. Additionally, while explaining consent 
orally provides the option for participants to engage in a dialogue about the research process, 
and thus gain better understanding, the researcher's nonverbal cues, such as tone of  voice 
and behavior, may bias the information being provided (Silverman, 1996). More research is 
needed to better understand how patients wish to be approached regarding research 
participation and informed consent (Kaasa & De Conno, 2001). 
Exceptions 
 In some situations, it may be impossible to obtain consent in the population or to 
conduct the research in a population that is capable of  providing consent. In these cases, 
researchers may seek approval from their ethics board to forgo the informed consent 
process. Although there is precedence for this, there is controversy concerning whether or 
not this method is ethically sound (Hardy, 2000). Hardy (2000) argues that this approach may 
be acceptable if  patients are unable to provide their own consent, seeking proxy consent 
would result in delay that would be detrimental to the treatment's efficacy, participation 
involves minimal risks that are comparable to the risks present in standard treatment, and the 
research can not be done with a population that can be expected to give consent, such as 
healthy volunteers. 
Summary 
 In order to ensure voluntary consent, researchers must understand how their 
relationship with potential participants may influence the decision to participate. They must 
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also be prepared to assess competence to consent, either formally or informally. In cases in 
which potential participants are not competent to provide consent, consent may be obtained 
through proxy or in advance. Process consent, in which consent is obtained at every data 
collection point, is recommended for longitudinal studies.  
Recruitment 
 Once the study design is solidified and the informed consent procedures are 
determined, study recruitment can begin. Because hospice and palliative care populations are 
so heterogeneous, inclusion and exclusion criteria must be developed to recruit patients who 
are applicable for the study and who are likely to complete participation. Additionally, 
researchers must decide how they will access this population while minimizing inappropriate 
gate-keeping and how they will introduce their study to potential participants. Lastly, 
researchers should be aware of  the factors affecting the interest of  potential participants in 
research participation. 
Inclusion/Exclusion Criteria 
 The development of  inclusion and exclusion criteria is a necessary part of  research 
design and recruitment. Appropriate inclusion and exclusion criteria increase the likelihood 
that recruitment will target individuals who are relevant for, and likely to complete, study 
participation.  Additionally, appropriate inclusion and exclusion criteria can lower the 
probability that participants from this sensitive population may be harmed by their 
participation. In a longitudinal study of  the palliative care needs of  older adults with heart 
failure, Barnes et al. (2005) assumed that individuals who were cognitively impaired, 
psychotic, or severely mentally ill were more likely than others to be unable to successfully 
complete study materials and to be alarmed by the issues raised in a palliative care study. 
 24 
Along similar lines, Williams, Shuster, Clay, and Burgio (2006) excluded potential participants 
who had been enrolled in hospice services for less than a week or who were considered by 
the hospice nurse of  physician as too sick to participate in their study exploring hospice 
patients' hypothetical interest in research participation.  
 However, using inclusion/exclusion criteria that are too stringent can limit study 
recruitment. Mitchell and Abernethy (2005) compared the methodologies of  two studies of  
palliative care patients. The researchers of  one study approached only patients who had been 
been approved by the patients' palliative care staff, general physician, and caregiver and who 
had a life expectancy of  over a month. Of  the 1137 potential participants screened, 52% 
were eligible for inclusion, and 51% of  their sample died or withdrew before one month. In 
contrast, the researchers conducting the contrasting study used maximal inclusion criteria 
and minimal exclusion criteria to facilitate eligibility. Of  the 1949 potential participants 
screened, 79% were eligible for inclusion. There is a fine balance to be reached in order to 
protect potential participants while simultaneously facilitating a large enough sample size to 
account for the high attrition and withdrawal rate that is likely in this population. 
 Life expectancy is an important factor to take into account with research with 
hospice and palliative care populations, especially in longitudinal studies. As Jordhøy et al. 
(1999) point out, “The main challenge, however, is to define eligibility criteria that can ensure 
patients' entry at a time when survival will be long enough for the supposed effect both to 
occur and to be assessed” (1999, p. 307). Unfortunately, life expectancy is commonly 
overestimated (Jordhøy et al., 1999; Mitchell & Abernethy, 2005). In determining inclusion 
and exclusion criteria, it is important to allow for a reasonable length of  time before follow-
up data is collected (Jordhøy et al., 1999; Kaasa & De Conno, 2001), and to consider using 
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prognostic factors (e.g., performance status) and providing an allowance for overestimation 
of  life expectancy (Jordhøy et al., 1999). In shorter-term studies, including patients who have 
a short life expectancy may increase the likelihood of  gate-keeping by ethics boards, medical 
professionals, and/or families. Hudson et al. (2005) recommend excluding patients that are 
very unwell or very close to death in studies which do not require patients with these 
characteristics in order to lessen the likelihood of  gate-keeping problems. 
 Additionally, mental status has been identified as an important eligibility 
consideration for studies and clinical trials with palliative care patients due to its implications 
in informed consent and the ability for patients to participate in the tested interventions 
(Bakitas et al., 2006; Dobratz, 2003). Dobratz (2003) suggested using a baseline cognitive 
assessment tool to assess for cognitive impairments in all potential participants, regardless of  
diagnosis. However, excluding potential participants on the basis of  mental status may 
exclude a large portion of  the palliative care and hospice population and result in a sampling 
bias. Thus, it is important to consider how the use of  mental status as an inclusion/exclusion 
criterion will effect the generalizability of  the results (Bakitas et al., 2006).  
 Because hospice and palliative care patients constitute a diverse range of  age, 
functional ability, cognitive status, and life expectancy, different exclusion criteria may be 
needed for different segments of  this population. In order to increase flexibility and 
sensitivity to unforeseen problems in study recruitment, Hopkinson, Wright, and Corner 
(2005) left their inclusion and exclusion criteria open to adjustment during data collection as 
well as protocol development.  
 However, the benefits of  this method can be detrimental in studies which use 
recruiters outside the research team. Bakitas, Lyons, Dixon, and Ahles (2006) recommend 
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that eligibility criteria be “clear, objective, and easily understood by recruiters and referring 
clinicians” (2006, p. 278). Additional thought must be put in to the wording of  eligibility 
criteria due to the sensitive nature of  end-of-life research. In regards to posters or flyers used 
to recruit participants, Bakitas et al. (2006) warn : 
 [Translating eligibility criteria into lay language] calls for creativity in recruiting 
seriously ill patients, some of  whom will be unaware of  their 'eligibility' as their 
condition may not have been presented to them by their physician as 'serious' or 'life-
limiting'. Even when clinicians inform patients of  their advanced illness status, 
patients may be in denial regarding the seriousness of  their illness and unlikely to 
identify with an advertisement that is looking for 'seriously ill, dying, or terminally ill' 
patients. (p. 278) 
Thus, it is important to consider who is being targeted by recruitment materials when 
considering how inclusion and exclusion criteria should be conveyed. 
Access 
 Conducting research with hospice and palliative care patients may involve passing 
several levels of  gatekeepers, including ethics boards, medical staff, hospice staff, family, and 
caregivers. In order for research to be successful, it is essential that researchers be able to 
obtain the support and understanding of  all levels involved in gaining access to this 
population. Inappropriate gate-keeping has two main consequences: restricting patients' 
autonomy and reducing research quality (Hudson et al., 2005). Gatekeepers can reduce the 
representativeness of  the sample and the generalizability of  the data by introducing sampling 
bias. Additionally, gatekeepers can misemploy the time and efforts of  both researchers and 
participants. As Hudson et al. (2005) explain, “When patients or families participate in a 
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study weakened by gate-keeping that prevents sound conclusions, their time and energies are 
misused. Given the limited life expectancy, it is imperative their contributions are 
worthwhile” (p. 166). Thus, it is important to understand how and why gate-keeping can 
occur in hospice and palliative care research, as well as what can be done to prevent it. 
 Because hospice and palliative care patients are a vulnerable population, there is 
contention about their appropriateness to participate in research (Hudson et al., 2005; Larkin 
et al., 2008). As discussed previously, there is debate about whether hospice patients should 
be excluded as research participants due to their end-of-life status and vulnerability or 
included to protect their rights to autonomy. The paternalism of  ethics boards was a 
common complaint in a focus group of  end-of-life researchers. While the researchers agreed 
that potential studies should be scrutinized and their ethicality ensured, there was shared 
concern that ethics boards “[acted] as gatekeepers for perceived 'vulnerable' participants, 
rather than seeing them as individuals capable of  making their own decisions” (Kendall et al., 
2007, p. 3). 
 Medical and hospice staff  are often used as referral sources in hospice and palliative 
care research in order to recruit individuals who are most likely to be able to participate 
successfully and without harm (Barnes et al., 2005; Buss & Arnold, 2004; Dobratz, 2003; 
Hopkinson et al., 2005; Kaasa & De Conno, 2001; Kendall et al., 2007; Phipps et al., 2005; 
Storey, 2004; Terry et al., 2006; A. Williams et al., 2005; C. J. Williams et al., 2006; Wright et 
al., 2006). While medical and hospice staff  are invaluable for this purpose, problems can arise 
when these professionals block patients from participation for reasons other than the stated 
inclusion/exclusion criteria. As Barnes et al. (2005) point out, “Although clearly well 
intentioned, this responsibility for patient protection may cause sample bias, as only those 
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deemed 'well enough' may be put forward as potential participants” (p. 322). Other 
researches have described encountering this problem when working with hospice and 
palliative care populations (Addington-Hall, 2002; Kendall et al., 2007).  Barnes et al. (2005) 
recorded that seven of  the primary care practices from which patients were recruited 
removed 31 potential participants (2% of  the participants produced by preliminary search) 
for reasons other than the exclusion criteria, evidencing the problem that gate-keeping can 
cause in unbiased study recruitment. This may become even more problematic in studies 
which involve a control or placebo group. As one researcher acknowledged, “Even the 
primary investigators were slow to recommend the study to their own patients because of  
the placebo control design” (Storey, 2004, p. 393).  
 Buss and Arnold (2004) reported the reservations of  the nurses involved in recruiting 
hospice patients for a study measuring the safety and effectiveness of  an anti-nausea drug. 
They found concern about the value of  the study, the risk and burden to dying patients, and 
the ethics of  a placebo trial were common worries. Because medical staff  often play a key 
role in participant selection and recruitment, educating involved professionals on research-
related issues, especially the ethical challenges of  conducting research with hospice and 
palliative care patients, is an important way to decrease inappropriate exclusion of  potential 
participants (Bakitas et al., 2006; Kaasa & De Conno, 2001). Assuring that recruitment does 
not unduly increase the responsibilities of  medical and hospice staff  can increase participant 
recruitment (Barnes et al., 2005). For example, Bakitas et al. (2006) provided referring 
clinicians with flyers and pocket cards explaining the relevant inclusion/exclusion criteria, as 
well as scheduling meetings with each group to provide professionals with an opportunity to 
ask questions and raise concerns about the study. They found very few instances of  gate-
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keeping when the clinicians had a clear understanding of  the eligibility criteria.  
  While researchers do not necessarily need family or caregiver permission to invite 
palliative care or hospice patients to participate in research, they often act as gatekeepers in 
providing access to these patients (Hopkinson et al., 2005). For example, Phipps et al. (2005) 
described how in some cases, the caregiver would answer the researcher's call at the time of  
recruitment and thus become the researcher's initial contact. In this study, thirteen potential 
participants were excluded because the caregiver declined on the patient's behalf. While 
caregivers may act in what they feel is the best interest of  the patient, caregivers often have a 
different perspective on the patients' level of  illness and ability to participate than the 
patients themselves. It has been found that caregivers of  hospice patients perceived level of  
illness as a barrier to research participation more frequently than the patients themselves 
(49% versus 39%, respectively; C. J. Williams et al., 2006). Also, caregivers were more 
concerned about emotional distress or pain as consequences of  research participation (24% 
versus 13%;  C. J. Williams et al., 2006). Thus, while caregivers may feel appropriately 
protective of  the family members under their care, they may not make the same choices that 
the family members would make for themselves regarding research participation. 
 Hudson et al. (2005) suggest several methods to decrease the likelihood of  gate-
keeping in hospice and palliative care research. For example, offering information sessions 
and brief  face-to-face updates to recruiting medical professionals may increase their 
understanding of  the study and of  recruitment, as well as offering professionals the chance 
to bring up concerns about the study and to problem-solve with the researchers. Also, 
excluding patients who are very ill or have a very limited life expectancy may increase study 
recruitment, as gate-keeping is more likely to occur with patients who are perceived as very 
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vulnerable. Lastly, excluding medical professionals who are involved in the direct care of  the 
patient may decrease the possibility of  medical professionals inappropriately protecting 
patients by not offering the opportunity for study participation or by discouraging patients 
from participating. The controversial nature of  this final suggestion will be further discussed 
in the Discussion section. 
Preliminary Contact 
 Medical professionals and researchers are often the first point of  contact for 
potential participants in this population. Researchers investigating patients' preference for 
being approached about end-of-life research have found that patients desire to be 
approached by the medical professionals most involved with their care rather than the 
researchers conducting the study (Terry et al., 2006; A. Williams et al., 2005; C. J. Williams et 
al., 2006). This may be especially important when working with minority or stigmatized 
populations who may be more mistrustful of  the researchers and able to communicate more 
openly with the medical professionals they already have a connection with (A. Williams et al., 
2005). While having medical professionals explain and introduce the study to potential 
participants increases the burden of  participation on the professionals, it may also decrease 
gate-keeping and sampling bias by giving medical professionals more control over the timing 
of  study introduction. In a study in which medical clinicians were responsible for referring 
patients to participate, researchers found that the referring clinicians rarely neglected to 
mention the study to eligible patients and would often adjust the timing of  recruitment to 
account for factors such as distress about a terminal diagnosis (Bakitas et al., 2006). However, 
there is concern that including medical professionals directly in the recruitment process may 
introduce more opportunity for gate-keeping and inconsistent recruitment approaches 
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(Hudson et al., 2005). 
Interest 
 Researchers have found indications that patients at the end-of-life are indeed 
interested in participating in research through both formal research and their experiences 
conducting research with other aims in this population (Hopkinson et al., 2005; Kaasa & De 
Conno, 2001; Kendall et al., 2007). Williams et al. (2006) found that 46% of  a sample of  
hospice patients reported being interested in research involving surveys or interviews and 
45% reported being interested in research involving therapeutic interventions. 
 There are many reasons why hospice and palliative care patients are interested in 
participating in research. Many participants express willingness to participate in research in 
order to help future patients or the care providers (Casarett, Kassner, & Kutner, 2004; 
Dobratz, 2003; Gysels et al., 2008; Jordhøy et al., 1999; Kendall et al., 2007; Terry et al., 2006; 
Wilkie, 1997). As one study participant explained, “It would be a way to give something back 
now before I die, I would have done something good for the future” (Terry et al., 2006, p. 
408). One study found a wide variety of  motivations for participating in research reported by 
hospice patients, including helping the doctor or nurse (37%), feeling good about helping 
others (33%), maybe feeling better (28%), improving symptoms (24%), contributing to 
science (22%), having a sense of  purpose (20%), adding meaning to life (19%), the possibility 
of  being followed more closely by the patient's doctor or nurse (19%), getting better care 
(14%), or having the opportunity to be social (11%, C. J. Williams et al., 2006). Having the 
opportunity to be social may be especially important for patients who have suffered disability 
arising from their illness and who may feel isolated (Gysels et al., 2008). Having the 
opportunity to provide feedback regarding services received may also be an important 
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motivator in patients receiving hospice or palliative care services (Gysels et al., 2008). 
Interestingly, Phipps et al. found that patients who are in more pain may be more likely to 
participate in research (2005). They hypothesized this may be because patients hope that 
participation will mean their pain issues are better addressed. This finding has an important 
implication for recruitment within these population, as researchers need to be prepared to 
refer patients with treatable pain problems that are not the focus of  research to appropriate 
clinicians. (Phipps et al., 2005). 
 There are also many barriers to research participation in this population. Hospice 
patients were more likely than ambulatory senior citizens to see being too sick, having too 
little energy, and concern for creating caregiver burden as being barriers to research 
participation (C. J. Williams et al., 2006). Phipps et al. (2005) recorded the reasons made by 
end-of-life patients for refusing to participate in research. They found other priorities, such 
as spending time with family, were cited by 42% of  refusing patients. Research-related 
concerns, such as having had a bad experience with research participation in the past, were 
cited by 36% of  refusing patients and health-related concerns, such as physical weakness or 
emotional distress, were cited by 28%. General disinterest was cited by 61%, making it the 
most commonly used reason for participation refusal. When consenting and refusing patients 
were compared, they found that consenters thought they had more to gain from 
participation than refusers. Additionally, consenters reported that aches and pains were more 
problematic for them as compared to refusing patients. Thus, while many hospice and 
palliative care patients demonstrate interest in participating in research, there are many 
motivations  and barriers which come in to play when making the decision to participate.  
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Summary 
 In order for researchers to recruit effectively for their studies, inclusion/exclusion 
criteria, access to the hospice and/or palliative care population, preliminary contact 
procedures, and potential participant interest must all be considered. When developing 
inclusion/exclusion criteria, researchers must seek to avoid criteria that are too liberal, which 
may result in the inclusion of  participants who are not members of  the target population, 
who are unlikely to successfully complete data collection, or who are likely to be harmed by 
data collection, and to avoid criteria that are too strict, which may result in a low sample size. 
In particular, life expectancy is an important factor to consider when making these 
considerations. Researchers must also review what gatekeepers lie between them and the 
target population and how best to negotiate preliminary contact so that the greatest possible 
number of  potential participants are offered the opportunity to participate while those who 
are inappropriate to participate in research are avoided. Lastly, researchers should be aware 
that there is real interest in participating in research in the palliative care population and be 
knowledgeable about the many factors which involve patients' decisions whether or not to 
participate. 
Risk and Benefit Analysis 
 It is the researchers' responsibility to ensure that the potential risks and benefits of  
participation are known, minimized when possible, and made clear to the potential 
participants. Such risks may include fatigue, emotional distress, and participation burden. 
Additionally, the possibility of  physical and/or emotional benefits should be considered, 
maximized, and disclosed. 
 
 34 
Possible Risks 
 It can be particularly difficult to distinguish what qualifies as a risk or burden in 
research with hospice and palliative care research as the priorities of  patients often change at 
the end of  life (Casarett & Karlawish, 2000). Given the unique experiences and concerns of  
these individuals, it may be inappropriate to use the standards of  daily life as a means for 
assessing risk (Casarett & Karlawish, 2000). Research risks are generally defined as “the 
probability of  an adverse medical event or undesirable outcome” (Casarett, 2005, pp. S-153). 
Alternately, research burden is defined as “unpleasant features of  participation in a study that 
are more certain, and which are better thought of  as inconveniences” (Casarett, 2005, pp. S-
153-S-154). 
 Fatigue. It is important for researchers to be aware of  the potential for study 
participants to become fatigued during the process of  participation. As Dobratz (2003) 
noted in her study of  home hospice patients, 3 out of  113 potential participants were 
deemed too fatigued to participate in the study during the consenting phase and an additional 
2 participants discontinued participation after only a few minutes due to fatigue. Of  the 97 
participants who completed data collection, 7 became fatigued to the point where they 
required multiple sessions to complete the process. While these numbers are small compared 
to the number of  potential participants, there is nonetheless a need for researchers to 
monitor for fatigue and to modify the data collection process as needed in order to prevent 
harm to participants. 
 Emotional distress. There are many possibilities for emotional distress in psychological 
research participation. This seems to be especially true in research with hospice and palliative 
care populations. In order to protect the well-being of  research participants, researchers must 
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understand what may trigger emotional distress in participants. 
 The wording of  research materials may be very distressing for participants who are 
unaware of  the terminal nature of  their diagnosis or the meaning of  the term “palliative 
care” (Addington-Hall, 2002; Barnes et al., 2005; Seymour et al., 2005). It is common for 
researchers to reword study materials in a more neutral way to prevent this distress. For 
instance, Barnes et al. used the term “heart condition”, as opposed to “heart failure” in the 
materials used in their community-based study of  heart failure. However, this technique has 
its disadvantages. As one researcher queried, “How do you identify people who actually are 
dying and how do you write it up so that you don't upset some people because they still think 
they're going to get better?” (Kendall et al., 2007, p. 4). There is also concern that rewording 
study materials may restrict the amount of  information that potential participants have on 
which to base their decision to participate (Addington-Hall, 2002). The fine line between 
minimizing distress and limiting informed consent is not clear in this area (Addington-Hall, 
2002). 
 Similarly, there is concern that recalling the experience of  being terminally ill or dying 
may provoke distress or remind participants about the seriousness of  their situation (Plant, 
1996). A focus group of  hospice and palliative care researchers pointed out that the ability of  
the researcher to monitor the level of  distress in the participant, bring the research to an 
emotionally safe close when the participant became too distressed, and ensure the participant 
had continued support if  necessary was an important aspect of  preventing harm to 
participants (Kendall et al., 2007). As Wilkie (1997) expresses, “The investigator should be 
sufficiently skilled to know when to stop asking questions” (p. 323). 
 Wilkie (1997) also points out that the potential benefit of  participants being 
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encouraged to express feelings and discuss experiences with researchers may carry the 
possibility of  harm. As she states, “If  participating in the research has become 'therapy' for 
the patient, what happens when the study finishes?” (1997, p. 324). Participants may also be 
at risk of  feeling guilt after discussing their relationships with care providers, partners, or 
family members with researchers (2002).  
 While there is good reason to be concerned about the risk of  emotional distress in 
participants, researchers have noted a low incidence of  distress among participants(Wright et 
al., 2006). Wright et al. (2006) noted that none of  the cancer patients who served as co-
researchers in their study of  palliative care services reported being distressed as a result of  
mediating focus groups on this subject. Although, it should be noted that the authors did not 
operationalize how this information was collected, and it appears co-researchers were 
expected to voluntarily report distress if  they experienced it. In a post-focus-group 
evaluation questionnaire, none of  the participants reported distress as a result of  
participating in a group mediated by a fellow cancer patient.  
 Burden. Research participation often entails burden for participating hospice and 
palliative care patients. Furthermore, burden that may be minimal for other populations may 
unduly burden participants who are at the end of  life, have limited time with which to 
participate in research, and may have other priorities (Casarett & Karlawish, 2000). Several 
strategies exist for reducing or eliminating potential burden. Researchers can use 
retrospective data or assessment tools that are already routinely administered by medical staff  
(Head & Ritchie, 2004). They may also pilot the materials to be used in a study in order to 
ensure that the burden placed on participants is feasible and necessary (Barnes et al., 2005). 
Once the data collection process begins, researchers can minimize the burden on participants 
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by being flexible in where, when, and how data is collected (Casarett, 2005). For example, 
phone interviews may create less burden for some participants than an in-home interview, or 
several short data collection sessions may be less burdensome than one longer one. 
Possible Benefits 
 While research participation often entails burden and risk, there is also the possibility 
for participants to reap benefit from the experience. Studies which involve new 
pharmacological treatments or treatment methodologies may offer participants the 
opportunity for an increased quality of  life (Casarett, 2005). Casarett points out that in these 
cases, researchers must consider how the findings of  these studies can be applied to the 
research participants in a timely manner as their limited life expectancy may mean that they 
do not live enough to experience the implementation of  new standards of  treatment. 
 Although a large portion of  psychological research does not offer direct benefit to 
participants (Wilkie, 1997), participation may be of  value in other ways. Participants may feel 
empowered by having their voices heard and expressing their feelings (Plant, 1996; Wilkie, 
1997). As one focus group participant commented, “When I spoke to [researcher's name] it 
really helped me. Because I felt that it was somebody listening, and I know it helped me” 
(Kendall et al., 2007, p. 3). Other participants may find pleasure and an increased sense of  
worth in knowing that they have done something to help others (Dobratz, 2003; Plant, 1996). 
Fine explains, “. . . instead of  additive burdens, there is oftentimes perceived benefit, through 
'helping', 'companionship', 'attention', and similar positively viewed attributions of  being 
involved in a social enterprise” (2003, p. S58). One group of  palliative care patients stated 
that the questionnaire they had completed regarding the symptoms they were experiencing 
had facilitated discussions that were therapeutic and beneficial to both themselves and their 
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families (Hopkinson et al., 2005).  
 Williams et al. (2006) explored hospice patients' interest in participating in research as 
well as the perceived benefits of  participation. They found that hospice patients were more 
likely than ambulatory senior citizens to experience the opportunity to help their doctor or 
nurse (37% versus 24%), the potential to improve their symptoms (25% versus 10%), the 
opportunity to have a sense of  purpose in their life (20% versus 11%), and the opportunity 
to be followed more closely by their doctor or nurse (19% versus 9%) as benefits of  
participation. 
Summary 
 The most prevalent potential risks of  participating in research for hospice and 
palliative care patients appear to be fatigue, emotional distress, and burden. It is important 
for researchers to understand that fatigue may cause undue harm to participants and limit 
their ability to participate. In these cases, researchers must be willing to discontinue 
participation or break participation up into smaller segments if  desired. Emotional distress 
can be caused by many facets of  the research experience which may include insensitive 
wording of  materials (especially if  the participant is unaware of  the nature of  their 
prognosis), recollection of  the experience of  being very ill, or guilt at discussing their 
relationships with caregivers, partners, or family. While low distress has been reported, it is 
vital that researchers be competent to monitor distress throughout participation and end 
participation in an emotionally safe way if  participants do become distressed. Because people 
at the end of  life often have different priorities from the general population, minimizing 
participation burden is essential. Where there are emotional or physical benefits, such as the 
feeling of  being heard, enjoyment of  being altruistic, or the experience of  improved quality 
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of  life as a result of  receiving a new treatment, researchers should seek to maximize these 
effects. 
Ethical Issues 
 In working with hospice and palliative care patients, researchers must consider the 
ethical issues of  creating ethical research goals, managing dual roles and role conflict, and 
protecting confidentiality and data access. While these are vital to consider in research with 
hospice and palliative care patients, it is important to note that these issues are not unique to 
this population (Casarett et al., 2003). As Fine asserts, “these are the same types of  
considerations that attend research in other high-risk populations, such as premature infants, 
burns victims, HIV or bone marrow transplant patients, to name a few examples where there 
is considerable research precedent” (2003, p. S56). Fine points out that “insufficient funding, 
pragmatic challenges, and sociological/cultural barriers limit research in this area, not ethical 
constraints per se” (2003, p. S53). While the following issues may be problematic and 
necessitate consideration on the part of  researchers, they are not inevitable barriers to 
conducting research with this population. 
Creating Ethical Research Goals 
 Because participants are willing to accept the risk of  harm and burden in research 
participation, researchers must in turn seek to maximize possible benefit and minimize 
potential risk (Casarett, 2005). Seymour and Skilbeck (2002) suggest using the ideas of  goal-
based morality, duty-based morality, and rights-based morality to conceptualize the balance 
between the research outcome and risk/benefit to participants. In goal-based morality, 
researchers aim to produce research that will be maximally beneficial to the population, if  
not to the participants themselves. In this view, producing research that is generalizable to 
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the greatest number of  individuals is the priority. Comparatively, in duty-based morality the 
benefit of  the participant is weighted over the research goals. Value is placed on making the 
research experience something that is beneficial to participants rather than ultimately 
generalizable. Researchers using a rights-based morality approach place emphasis on the 
participant's rights to choose to participate in the research process and evaluate the potential 
risks and benefits of  the experience. According to Seymour and Skilbeck, it is important for 
researchers working with hospice and palliative care patients to balance these three 
perspectives in order to create research that is ethically sound. 
Dual Roles and Role Conflict 
 The process of  research often places individuals in the role of  both investigator and 
caregiver (e.g., Raudonis, 1992). In this situation, participants may feel coerced into research 
participation because they are afraid of  receiving a lower level of  care if  they refuse to 
participate in proposed research or provide negative feedback (Addington-Hall, 2002; Kaasa 
& De Conno, 2001; Plant, 1996; Wilkie, 1997). Confusion about the role of  the researcher 
may cause distress once data collection is completed. Situations in which a participant 
mistakes a researcher as a member of  their clinical care team may result in confused 
communication between the patient and medical staff  as well as disappointment when 
research is completed and contact with the researcher ends (Seymour & Skilbeck, 2002). 
 Researchers themselves may have difficulty balancing these two divergent roles even 
if  the researcher is not directly involved in the medical care of  the particular patient (Casarett 
& Karlawish, 2000; Raudonis, 1992). While the clinician uses their available skills to alleviate 
the pain and suffering their patients are experiencing, the researcher's duty is to record data 
from participants as objectively as possible. Clinicians in the role of  researchers may feel 
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pulled to use their clinical skills and knowledge in reaction to information gained in the data 
collection process (Plant, 1996). Raudonis (1992) describes two situations in which she felt 
such role conflict. In the first, she describes how a very articulate, informative interviewee 
declined to continue her participation after her condition deteriorated. Raudonis discusses 
how, as a researcher, she was disappointed in the loss of  a valuable participant, but as a nurse 
she approved of  the patient's decision to discontinue participation. In the second, she 
describes how she stayed with a participant after data was collected to serve him lunch and 
help him back to bed at his request. She states: 
Although some readers may question the presence of  conflict, the author 
experienced some distress after the incident and questioned if, as a researcher, she 
should engage in such activities. Reflecting on the experience, she decided it was the 
nurse responding to the individual's needs and that she would respond accordingly if  
the situation were repeated. In some small way, as a nurse, the author was able to 
help this person who had chosen to share his experience with her. (Raudonis, 1992, 
p. 245) 
Role conflict issues may also involve issues such as confidentiality. For example, there may be 
a dilemma if  a research participant discloses about inadequately treated symptoms in the 
process of  data collection (Casarett & Karlawish, 2000). While the issue of  reporting will be 
discussed more thoroughly in the section titled “Confidentiality and access to data”, 
clinicians who are conducting research must be aware of  this facet when they are clarifying 
their role as researcher. In order to reduce the risk of  harm to both patient and researcher, 
researchers must clearly outline their role before the process begins. 
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Confidentiality and Access to Data 
 Researchers must determine how the confidentiality of  the participants and data will 
be protected before the study begins. This is especially important when the research targets 
information which may be important for the care of  the patient. For instance, participants 
may report symptoms which are being inadequately managed. Casarett and Karlawish (2000) 
outline three possible solutions to this kind of  disclosure: Investigators may decide to never 
disclose such information to the care provider, always disclose such information to the care 
provider, or encourage the patient, if  they are considered competent, to report the 
information to their care provider themselves. Casarett and Karlawish point out that the first 
option places the highest value on confidentiality, where the second option places the highest 
value on maximizing benefit and minimizing harm. The third option strikes the best balance 
between these two important ethical areas. They also point out that the researcher may offer 
to contact the care provider with the permission of  the participant, but should never contact 
the care provider without participant permission. In the case that the participant is unable to 
report the information to their care provider, Casarett and Karlawish state that “a 
presumption should exist in favor of  disclosing to a patient's provider any information that 
might assist in the alleviation of  that patient's symptoms” (p. 135). Researchers must 
determine the answers to these questions prior to the beginning of  the study and inform 
patients of  what, when, and to whom information will be shared in the informed consent 
process (Wilkie, 1997). 
Summary 
 Before a project begins, researchers must consider how to create ethical study goals, 
determine how they will manage and minimize potential harm from dual roles, decide how 
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they will best protect the confidentiality of  participants and data, and determine what 
information will be shared with care providers. In particular, researchers must seek to strike a 
balance between maximizing potential benefit to participants and creating a study that is 
generalizable and able to be applied to help other patients, determine if  they have a dual 
relationship with participants and how this can best be managed, and determine when and 
how information relevant to the care of  patients will be disclosed to their care provider. 
Methodological Issues 
 Researchers must use the soundest methodology possible in order to produce 
optimally valid and generalizable results. In order to do this, they must have awareness of  the 
effects of  selection bias, attrition, and withdrawal on their findings. When interviews or 
questionnaires are used, researchers should seek to maximize ease of  use and minimize 
participant burden. Assistance (e.g., help reading or completing study materials) may be 
necessary to minimize the amount of  missing data and in some cases, the use of  a proxy to 
participate on behalf  of  the patient may be optimal, although not without its own challenges. 
Lastly, researchers must plan statistical analyses to reduce bias and best process data sets with 
missing values. 
Selection Bias 
 Self-selection bias, in which participants with a certain trait may be more or less likely 
to choose to participate in the research study, is one possible limitation of  research studies 
with hospice and palliative care patients as participants (C. J. Williams et al., 2006). As a 
result, researchers should take care to analyze what effect selection bias may have on their 
results. For example, Williams et al. pointed out that their finding that 45% of  hospice 
patients expressed willingness to participate in research was likely over-inflated due to the 
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fact the patients had chosen to participate in a research survey to begin with. Researchers 
should seek to reduce the effects of  selection bias whenever possible and, like Williams et al., 
disclose the likely effects of  selection bias on their findings when it cannot be eliminated. 
Attrition/Withdrawal 
 Attrition due to participant death or withdrawal is a major obstacle to conducting 
research with this population (Jordhøy et al., 1999; Kaasa & De Conno, 2001). Death, 
discharge, or decline in cognitive function may be involved in attrition rates (A. Williams et 
al., 2005).  In a longitudinal study researching health-related quality of  life in palliative care 
patients, Kaasa and De Conno reported a median survival rate of  81 days after study 
enrollment and a withdrawal rate, defined as patients who dropped out of  the study before 
their death by not returning questionnaires, of  45%. Of  two longitudinal studies of  palliative 
care patients, Mitchell and Abernethy (2005) reported a 51% attrition rate due to death or 
withdrawal at the goal 3-week analysis in one study and a 54% attrition rate due to death or 
withdrawal at the goal 8-week analysis in the other. In the latter study, 15% of  participants 
withdrew from the study prior to death. Dobratz (2003) reported a withdrawal-and-attrition 
rate of  14% in her study of  home hospice patients. Because this study was not longitudinal, 
the percentage was calculated from the number of  patients who agreed to participate at the 
preliminary contact but either died or changed their minds before informed consent or data 
were collected. Bruera (1994) estimates that approximately 30% of  patients in studies longer 
than 14 days drop out due to noncompliance or complications. While the high attrition rates 
are problematic in this research, Williams et al. (2006) point out that conducting research 
with hospice patients is still feasible if  allowances for attrition are made when recruiting 
participants. 
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Assessments 
 Researchers must determine how assessments will be used to optimally collect 
research data. If  too many assessments are used, or if  the assessments are too long and 
tiring, researchers risk inducing fatigue in their participants and decreasing the amount of  
valid data collected. For these reasons, researchers in this population should only use 
assessments which are necessary and can be clearly justified (Bruera, 1994). Beyond the 
number of  assessments, researchers must consider how the interviews or questionnaires are 
to be constructed, if  objective indicators can be utilized, how assistance will be provided to 
participants, and if  proxies will be used for data collection. 
 Interview/questionnaire construction.  Appropriate interview and questionnaire 
construction is vital for collecting interpretable data. For example, researchers should be 
aware that long interviews or questionnaires are not only unlikely to be completed by 
participants, who may fatigue easily, but they may also increase gate keeping (Addington-Hall, 
2002). Fliss, Addington-Hall, and Higginson (2007) conducted research with palliative care 
patients using questionnaires and subsequently asked for feedback on several topics, 
including the structure of  the questionnaire. They then reformatted the questionnaire based 
on the feedback provided. The changes included increased font size, removal of  gray shading 
on alternate questions, increased size and boldness of  text describing the time period to 
which symptoms related, and development of  a large-print version for participants with 
vision problems. Additionally, they found that “In general, the questions on psychological 
rather than physical symptoms required more time and consideration, but no patient was 
unable to answer them or displayed distress” (p. 90). 
 Objective indicators. Although not applicable to all studies, Kaasa and De Conno (2001) 
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suggest that researchers collect objective data, such as tumor burden or biochemical markers, 
from hospice and palliative care patients whenever appropriate in order to increase the 
validity, reliability, and scope of  the data collected. As they explain, biological indicators may 
help to explain the method of  action of  palliative care treatments.  
 Assistance. While some participants may be able to complete the surveys and other 
materials necessary for study participation, others may need assistance. In one study, 
researchers asked palliative care patients to complete a series of  questionnaires over a period 
of  time and to report the level of  assistance they had received with each questionnaire 
(Jordhøy et al., 1999). Participants reported that they had received assistance with 31% of  the 
total questionnaires and that 23% of  those questionnaires had been completed for them by 
another person. Of  the questionnaires completed less than two months before the 
participant's death, the rate of  assistance rose to 50%. Dobratz (2003) reported that 28.8% 
of  the 97 hospice patients who completed study participation needed assistance in reading 
questions and recording answers due to physical impairment such as poor vision, physical 
weakness, or other physical handicaps.  
 Proxies. In some cases, it may be necessary for another individual to act as a proxy and 
provide information on behalf  of  the hospice or palliative care patient due to the patient's 
physical or cognitive decline or death (Bakitas et al., 2006). While proxies may be necessary 
to collect information in some cases, there has been some concern about the reliability of  
proxy reports (McPherson & Addington-Hall, 2003). McPherson and Addington-Hall 
conducted a review of  the relevant literature in order to clarify these issues. They reported 
that proxy reports of  service provision and evaluation and observable symptoms, such as 
immobility, activities of  daily living, fatigue, difficulty breathing, and vomiting, were reliable 
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in comparison to the patients' own reports. In contrast, proxy reports of  the patient's 
subjective experience, such as pain, mood disturbance, symptom distress, and thoughts, were 
less reliable. Better agreement between patients and proxies was found when simple 
questions and limited response options were used.  
 Bakitas et al. (2006) discussed the possibility of  requiring participants to have a family 
member or caregiver who is willing to act as a proxy in order to ensure that data is collected 
continuously until the participants' deaths. However, complications with this method arise 
early. The selection of  a proxy for research may affect the dynamics of  the family in 
situations when more than one caregiver or family member is heavily involved with the 
patient by putting more responsibility on one member (Kapo & Casarett, 2004). Other 
disadvantages may include increased cost and methodological issues (Bakitas et al., 2006). As 
Kapo and Casarett point out, using a proxy reporter may call for researchers to be available 
late in the evenings or at other times when caregivers may be most able to spend time away 
from caring for the patient in order to participate in the study. Researchers using proxy 
reporters must take care to be tactful with the timing of  data collection and avoid contacting 
the proxy for research purposes if  the patient is rapidly declining or struggling with 
uncontrolled symptoms (Kapo & Casarett, 2004). The use of  proxies may beneficially result 
in increased homogeneity, maximized internal validity, and reduced data attrition (Bakitas et 
al., 2006). Researchers using proxies also have the opportunity to continue collecting data 
after the participants' death (Kapo & Casarett, 2004). 
Statistics 
 In order for study results to be valid, appropriate statistical procedures must be used. 
Research with hospice and palliative care populations entails certain challenges which may 
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make statistical analyses of  the data more difficult, such as high rates of  missing data and low 
sample size. Researchers must choose statistical methods which will best overcome these 
challenges and produce useful results. 
 Missing data. Missing data is problematic because it reduces power to detect 
differences and introduces bias (Palmer, 2004). While a large number of  studies result in 
randomly missing data, missing data in hospice and palliative care samples tends to be non-
random and is usually related to changes in the participant's health state and level of  
functionality. Thus, is not appropriately replaced by typical methods such as estimation or the 
sole inclusion of  participants with complete data (Grande & Todd, 2000; Palmer, 2004). 
Palmer used three methods for working with missing data, including the exclusion of  
patients with missing data, the substitution of  the baseline value for missing values, and the 
use of  the last known value for subsequent missing values, to analyze one set of  data 
collected from palliative care patients in order to examine if  using different methods would 
significantly alter the results. She concluded that different methods of  estimating missing 
data did result in different conclusions being drawn from the data. Based on these findings, 
Palmer suggests:  
If  missing observations have occurred, publications should report analyses with 
more than one method of  estimating missing data as a form of  sensitivity analysis to 
determine if  the conclusions of  their study are 'robust' to the potential problems of  
missing data. (p. 618) 
At the least, researchers should be sure to clearly state the method they used to deal with 
missing data (Palmer, 2004). 
 Reducing bias in non-experimental research designs. Penrod and Morrison (2004) reviewed 
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two statistical methods for reducing the potential for bias in non-experimental, or 
observational, studies: propensity score matching and instrumental variables estimation. 
Propensity score matching is used to minimize selection effects on the estimation of  
treatment effects. In this method, each participant's likelihood of  being placed in the 
treatment group is estimated and used to stratify the sample. The treatment effect is then 
calculated for each stratum. Instrumental variables estimation  involves identifying a variable 
or variables that impact the participant's treatment but not impact the outcome variable. 
Once the identification is made, the researcher can determine what portion of  variation in 
the outcome variable is determined by the variable as opposed to the treatment. By utilizing 
these methods, researchers can enhance the statistical rigor of  observational research. 
Summary 
 Researchers must confront many methodological issues in conducting research with 
hospice and palliative care patients, including dealing with selection bias, attrition and 
withdrawal, effective use of  assessments, and suitable statistical methods. Researchers must 
take care to limit the use of  assessments to only those that are relevant and justifiable, and to 
construct interviews or questionnaires in a manner that optimizes ease of  use and minimizes 
participant burden. For example, questionnaires should use large, clear print, not contain 
shaded areas, and be available in a large-print version for those with vision difficulties. If  
objective indicators can be appropriately used in a study, it is suggested that they be included. 
Researchers should be aware that a high proportion of  participants may need assistance in 
reading or completing questionnaires, and in some cases, a proxy may be used to respond on 
behalf  of  patients. Lastly, researchers are obligated to use appropriate statistical analyses in 
order to produce results that are optimally valid and generalizable. 
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Summary of  the Literature 
 While there are many obstacles in conducting research with hospice and palliative 
care patients, they are not insurmountable. With careful preparation, researchers can plan for 
these areas of  difficulty and continue to produce research which can be used to better 
understand the needs, desires, and experiences of  this population and be applied to increase 
the quality of  life of  people at the end of  life. Although there has been some debate over the 
ethicality of  conducting research with this population, writers in the literature are 
overwhelmingly in favor of  supporting patients' rights to make an informed decision 
regarding research participation (Addington-Hall, 2002; Bruera, 1994; Gysels et al., 2008; 
Hudson et al., 2005; Kaasa & De Conno, 2001; Terry et al., 2006).  
 Adequate preparation time is essential to solid study design in this population 
(Seymour et al., 2005). This preparation may include obtaining IRB approval; identifying and 
carrying out training and/or education for involved individuals and organizations; clarifying 
access, researcher roles, and ethical conduct; and identifying the target population (Bakitas et 
al., 2006; Barnes et al., 2005; Seymour et al., 2005). Depending on the research goals, 
researchers may need to evaluate the advantages and disadvantages of  several applicable 
research designs such as randomized controlled trials, qualitative methods, phenomenological 
paradigms, case studies, focus groups, mixed methods, survey research, and collaborative 
approaches (Addington-Hall, 2002; Kapo & Casarett, 2004; Penrod & Morrison, 2004; 
Seymour & Clark, 1998; Seymour et al., 2005; Storey, 2004; Wallen & Berger, 2004; Walshe et 
al., 2004; Wilkie, 1997; A. Williams et al., 2005; Wright et al., 2006). Researchers should 
anticipate how attrition and withdrawal may affect the target sample size (Casarett, 2005) and 
consider how to maximize the diversity included in the sample (Kendall et al., 2007; Wright 
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et al., 2006). 
 Because hospice and palliative care patients are considered a vulnerable population, 
special considerations must be taken to ensure that their consent is informed and their 
participation is voluntary (Casarett et al., 2003; Morreim, 2006). One such consideration is 
the assessment of  competence to consent, which may be determined through formal or 
informal means (Bruera, 1994; Fine, 2004; C. J. Williams et al., 2006). In cases where patients 
cannot provide competent consent, researchers may collect dual or proxy consent (Casarett, 
2005), and advance consent is recommended when potential participants will be unable to 
provide consent at the time they become eligible to participate (Casarett, 2005; Casarett et al., 
2003). Regardless of  the type of  consent used, researchers must be aware of  the effects of  
wording and delivery on patient understanding and seek to make the informed consent 
process maximally effective. This may include wording the informed consent form to avoid 
potentially disturbing terms such as “terminally ill” and “end of  life”, emphasizing that 
potential participants are consenting to research rather than treatment, providing information 
orally, and providing an appropriate form of  back-up information (Plant, 1996; Silverman, 
1996; Speck, 1996; Terry et al., 2006). 
 In order to recruit patients who are eligible for the study and most likely to complete 
participation, researchers must design appropriate inclusion and exclusion criteria. While 
overly lenient inclusion and exclusion criteria may result in the inclusion of  participants who 
are inappropriate or unlikely to complete participation, overly strict criteria may result in low 
study recruitment. Some frequently mentioned inclusion and exclusion criteria in this 
population include life expectancy and mental status (Bakitas et al., 2006; Jordhøy et al., 
1999). In order to access potential participants, researchers may have to pass several levels of  
 52 
gatekeepers including ethics boards, medical staff, hospice staff, family, and caregivers. 
Certain strategies, such as offering informational sessions and excluding patients who are 
very ill or have a very limited life expectancy, may be beneficial to study recruitment (Hudson 
et al., 2005). While the recruitment process may be difficult, it appears that many hospice and 
palliative care patients are interested in research participation (Hopkinson et al., 2005; Kaasa 
& De Conno, 2001; Kendall et al., 2007; C. J. Williams et al., 2006). Participants have cited 
many reasons for participating in studies, including to help current or future patients and 
care providers, to feel good about helping others, to improve symptoms, to contribute to 
science, to have a sense of  purpose, and to increase social interaction (Terry et al., 2006; C. J. 
Williams et al., 2006). Conversely, there are also many barriers to research participation, such 
as illness, low energy, and the potential for caregiver burden (Phipps et al., 2005; C. J. 
Williams et al., 2006).  
 Research participation carries many possible risks and benefits. Such risks may 
include fatigue, emotional distress, and burden (Casarett & Karlawish, 2000; Dobratz, 2003; 
Kendall et al., 2007). Additionally, participants may reap direct and indirect benefits, such as 
new treatments, the feeling of  empowerment through helping others and having their voices 
heard, and opportunities for social interaction (Casarett, 2005; Fine, 2003; Plant, 1996)
 Researchers must confront many ethical issues when designing and conducting 
research in hospice and palliative care populations. Because participants accept the risk of  
burden and harm when participating in research, researchers must seek to maximize possible 
benefit and minimize harm while still producing research that is methodologically sound and 
generalizable (Casarett, 2005; Seymour & Skilbeck, 2002). The roles of  researcher and 
clinician may overlap in many settings, and researchers must clarify exactly what their role 
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will be (Casarett & Karlawish, 2000; Raudonis, 1992). The area of  confidentiality and 
inadequately treated symptoms may be especially problematic. Researchers must clarify if, 
how, and when they will break confidentiality in order to inform the primary care provider of  
problematic symptoms (Casarett & Karlawish, 2000).  
 There are also many methodological problems inherent in conducting research with 
this population. As in all research using volunteer participants, researchers must anticipate 
the effects of  selection bias and take this into account when attempting to generalize the 
results of  the study (C. J. Williams et al., 2006). Research with this population is especially 
vulnerable to participant attrition and withdrawal (Jordhøy et al., 1999; Kaasa & De Conno, 
2001), and the statistical analyses should take these problems into account. When interviews 
or questionnaires are used, they should be justified, constructed for the ease of  participant 
use, and require as little burden as possible (Addington-Hall, 2002; Bruera, 1994). The fact 
that many participants will require assistance in completing study materials should also be 
taken into consideration (Jordhøy et al., 1999). 
 The road to valid and generalizable research using hospice and palliative care patients 
is replete with possible hazards for researchers, participants, and research projects. But this 
does not minimize the need for continued research in this area or signify that such research is 
impossible or not worth the effort of  conducting. Rather, it highlights the need for 
synthesized guidelines to inform researchers and guide them through these potential 
problems. In the remainder of  this thesis, the focus will be on providing information on 
additional areas of  concern, summarizing the controversies in the literature, providing 
guidelines for researchers in this area, and identifying areas of  further research and 
clarification.
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Discussion 
 As evidenced by the sheer number of  articles on the topic of  hospice and palliative 
care patients, such research is certainly possible. However, as noted regarding the many 
pieces of  literature reviewed in this thesis, it is also very challenging. Researchers must have 
the time and understanding to carefully review, evaluate, and implement the most effective 
solutions to possible problems. In order to assist researchers in this area, the goal of  this 
discussion section will be to highlight additional areas of  consideration not reviewed 
previously, discuss the current controversies, offer synthesized recommendations for 
researchers, and call attention to topics in this area necessitating further research. 
Additional Areas of  Consideration 
 Although care was taken to make the review exhaustive, some potentially challenging 
areas of  conducting research with hospice and palliative care patients did not emerge in the 
literature. Such areas include abuse reporting and statistics with small sample sizes. 
Abuse Reporting 
 Depending on the laws of  their state, psychologists who are conducting research may 
be required to report suspected elder abuse (Bergeron & Gray, 2003). However, there is some 
debate in the child abuse reporting literature concerning whether research activities are 
included in the official capacity of  a psychologist, and thus covered by the mandated 
reporting statutes in most states (Allen, 2009). Due to the high proportion of  elderly 
individuals in this population, researchers should consult their state laws regarding abuse 
reporting and include such limits to confidentiality in the informed consent. 
Statistics and Small Samples 
 As previously discussed, the challenges involved in conducting research with hospice 
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and palliative care patients may result in a sample size that is smaller than desired. The 
minimum sample size needed may vary with the normality of  the distribution of  the variable. 
For example, a variable which is normally distributed may require a smaller sample size than 
one which is not normally distributed (Pett, 1997). In cases where the distribution of  the 
variable is not known and the sample size is small, nonparametric methods should be used in 
data analysis (Pett, 1997). 
Summary 
 The literature does not contain discussion of  every area that researchers in hospice 
and palliative care populations must take into consideration. Researchers must also consider 
how they will handle any disclosures of  abuse or neglect by elderly research participants and 
how they can utilize appropriate statistical methods despite the likelihood for small sample 
sizes. 
Controversies 
 Not all discussion of  the ethical and logistical issues of  conducting research with 
hospice and palliative care patients has been straightforward. Of  the topics reviewed, the 
issue of  whether it is ethical to include hospice and palliative care patients as research 
participants has received the most discussion. While it did not result in discussion in the 
literature, the suggestion of  excluding professionals involved in direct patient care from the 
recruitment process as a means of  minimizing gate-keeping will also be discussed. 
Including or Excluding Hospice and Palliative Care Patients as Research Participants 
 While there has been debate in the literature regarding whether it is ethical to include 
hospice and palliative care patients as research participants, the consensus is that it would be 
unethical to disrespect patients' autonomy by excluding them as potential research 
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participants (e.g., Addington-Hall, 2002; Gysels et al., 2008; Terry et al., 2006). After my 
review of  the literature, I agree with this consensus. While there are undeniably many issues 
which much be taken into consideration when designing research with hospice and palliative 
care populations, the challenges to designing appropriate, ethical research are not 
insurmountable, and research in this area is important to increase the quality of  care and to 
understand the needs and desires of  individuals at the end of  life. Additionally, participants 
may experience many indirect and intangible benefits from research participation. As long as 
participants are adequately informed of  the potential risks of  research and are not unduly 
burdened by participation, I think it is important to respect patient autonomy by extending 
the invitation to participate in appropriate research. 
Minimizing Gate-Keeping by Excluding Professionals Involved in Direct Patient Care 
 Researchers have suggested many ways of  reducing gate-keeping, such as excluding 
the professionals directly involved in the care of  the potential participant from recruitment 
(Hudson et al., 2005). While this could indeed reduce instances of  inappropriate gate-
keeping in study recruitment, it also goes against the suggestions and experience of  other 
researchers, as well as the reported wishes of  potential participants. Many researchers have 
used hospice and palliative care professionals to recruit patients who are most likely to be 
able to complete participation with the least likelihood of  harm (Barnes et al., 2005; Buss & 
Arnold, 2004; Dobratz, 2003; Hopkinson et al., 2005; Kaasa & De Conno, 2001; Kendall et 
al., 2007; Phipps et al., 2005; Storey, 2004; Terry et al., 2006; A. Williams et al., 2005; C. J. 
Williams et al., 2006; Wright et al., 2006). The most persuasive argument against this 
suggestion, however, may be the research documenting patients' desire to be approached 
about research by the professionals most involved in their care (Terry et al., 2006; A. 
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Williams et al., 2005; C. J. Williams et al., 2006). In light of  these findings and the many 
alternative possibilities for reducing gate-keeping suggested by Hudson et al. (2005), such as 
offering information sessions and brief  face-to-face updates to recruiting medical 
professionals and excluding patients who are very ill or have a very limited life expectancy, 
excluding involved medical professionals from recruitment may be ill-advised. 
Recommendations 
 In conducting research with hospice and palliative care patients, researchers face 
many challenges in the areas of  study design, informed consent, recruitment, risks and 
benefits, ethical issues, and methodological issues. The following recommendations include 
many previously suggested in the literature and others based on the information previously 
reviewed. In order to minimize these challenges and increase the quality of  future research, 
researchers should: 
1. Allow plentiful time for planning and study design (Seymour et al., 2005). 
2. Plan for high attrition rates (Jordhøy et al., 1999; Kaasa & De Conno, 2001). Attrtion 
rates of  30-50% have been found in longitudinal studies (Bruera, 1994; Mitchell & 
Abernathy, 2005) and 15% in one-time studies (Dobratz, 2003), with rate increasing 
over the length of  the study (Kaasa & De Conno, 2001), have been reported in the 
literature.  
3. Seek to increase diversity in samples by using culturally appropriate materials and 
involving the cultural community in recruitment (Kendall et al., 2007). 
4. Consider implementing a “silent opt-out”, in which patients can decline to participate 
through inaction, to minimize coercion. 
5. Use formal competence assessment when possible (Dobratz, 2003; Fine, 2004). 
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6. Use dual consent when proxy consent is required (Casarett, 2005). 
7. Use process consent in longitudinal studies (Addington-Hall, 2002; Head & Ritchie, 
2004; Kendall et al., 2007; Raudonis, 1992). 
8. Deliver informed consent orally, with simple, straight-forward written materials for 
participants to keep for reference (Speck, 1996). Researchers have reported that 
participants from these populations prefer oral, versus written, information (Terry et 
al., 2006). 
9. Understand the specific target population's understanding of  their life expectancy or 
terminal status and word recruitment materials accordingly to minimize distress and 
increase participant recruitment (Plant, 1996). 
10. Include life expectancy as an inclusion/exclusion criteria (Hudson et al., 2005 ; 
Jordhøy et al., 1999; Kaasa & De Conno, 2001). This will help ensure that 
participants will be able to complete study participation and decrease gate-keeping 
(Mitchell & Abernethy, 2005). 
11. Educate other involved professionals on research related issues, Researchers have 
reported this helpful in minimizing gate-keeping and maximizing study recruitment 
(Bakitas et al. 2006). 
12. Understand participants' preference to be approached by the medical professionals 
most involved in their care (Terry et al., 2006; A. Williams et al, 2005; C. J. Williams et 
al., 2006). 
13. Train data collectors to be alert to signs of  adverse effects (Dobratz, 2003; Wilkie, 
1997). Researchers involved in a focus group warned of  the potential harm that can 
be caused by data collectors who do not pay attention to the emotional state of  the 
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participant or who do not end data collection with hospice and palliative care patients 
if  a participant becomes distressed (Kendall et al., 2007). 
14. Use retrospective or routine assessment data whenever possible to minimize the 
burden to patients (Head & Ritchie, 2004). 
15. Conduct pilot tests if  there is concern about the burden or feasibility of  the planned 
study. Researchers have indicated that pilot tests are helpful to reduce participant 
burden and increase the likelihood that all needed data is collected (Barnes et al., 
2005). 
16. Be flexible with where, when, and how data is collected in order to reduce burden 
(i.e., collect data at the participant's residence, schedule data collection for times 
when they are usually most alert, collect data in several shorter sessions rather than 
one longer one). Researchers have reported that such steps can reduce the burden of  
research participation (Casarett, 2005). 
17. Seek benefit for participants in creative ways. 
18. Understand the potential for role conflicts or dual roles and clearly define roles as 
researchers and/or clinicians. Many researchers have discussed their experiences with 
role conflicts and dual roles in doing research with this population (Addington-Hall, 
2002; Kaasa & De Conno, 2001; Plant, 1996; Raudonis, 1992; Wilkie, 1997). 
19. Plan for how to deal with participant disclosure that is relevant to the patient's 
treatment and include this in the informed consent (Casarett & Karlawish, 2000; 
Wilkie, 1997). Follow Casarett and Karlawish's recommendation that the participant 
contact their medical provider, or offering to contact the medical provider on behalf  
of  the patient, as it respects the confidentiality and autonomy of  the patient while 
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addressing the problem of  unreported symptoms. 
20. Use only assessments which are necessary and can be clearly justified (Bruera, 1994). 
21. Use objective indicators when possible (Kaasa & De Conno, 2001). 
22. Be prepared to assist or have others assist participants with completion of  study 
materials. Researchers have noted that a large proportion of  hospice and palliative 
care patients will need assistance to complete study materials (Dobratz, 2003; 
Jordhøy et al., 1999). 
23. Consider how assistance may affect participant disclosure. 
24. Use proxies for service evaluation projects or when data is needed up to the time of  
death. Researchers have reported the reliability of  proxy reported for service 
evaluation projects and the utility of  proxy reporters for providing information after 
the patient can no longer be expected to participate (Kapo & Casarett, 2004; 
McPherson & Addington-Hall, 2003). 
25. Conduct  and report the results of  multiple analyses of  variables with missing data 
(Palmer, 2004). 
26. Use appropriate statistical methods if  the sample size is small. 
27. Disclose the possible effects of  selection bias when the study is published (see C.J. 
Williams et al., 2006). 
Areas of  Further Research 
 While a great deal of  literature exists concerning the ethical and logistical challenges 
of  conducting research with hospice patients, several areas could still benefit from further 
exploration. These areas include increasing the inclusion of  diverse populations in research, 
coercion in the consent process, proxy consent and the reliability of  proxy-provided 
 61 
information, and the role of  assistance on disclosure in research. For the purposes of  this 
discussion section, unless specified, the term 'research' is used to refer to published accounts 
of  researchers' experiences working with this population as well as empirical research studies, 
as both offer perspectives which can be useful to researchers working with hospice and 
palliative care populations. 
Increasing the Inclusion of  Diverse Populations 
 Many researchers have expressed concern regarding the small proportions of  ethnic 
minority individuals who participate in hospice and palliative care research (Kendall et al., 
2007). However, little of  the research covered in this review included discussion of  this issue. 
It would be beneficial for future literature to be made available which includes discussion of  
the challenge of  increasing the recruitment of  diverse individuals for research in this 
population and suggestions for overcoming this challenge. Additionally, researchers should 
seek to include diverse participants, such as racial and ethnic minorities, sexual orientation 
minorities, and people with disabilities, whenever possible. 
Coercion in the Consent Process.  
 While a great deal of  speculation regarding the role of  coercion in the consent 
process is present in the literature, this area of  research could benefit from more empirical 
investigation. For example, research on whether refusal rates vary by the relationship of  the 
researcher to the potential participant could be beneficial in determining how much the 
existing patient-researcher relationship affects the recruitment and consent process. 
Replication of  Terry and colleagues' (2006) focus groups of  hospice and palliative care 
patients may be especially helpful in determining which factors may be unintentionally 
coercive in research recruitment. Overall, increasing the understanding of  potentially 
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coercive aspects of  recruitment will be of  benefit to future researchers seeking to reduce 
coercion in their studies. 
Proxy Consent and the Reliability of  Proxy-Provided Information 
 The process of  proxy decision-making is not yet well understood and researchers 
could benefit from further research on the subject (Silverman, 1996). Areas of  potential 
exploration include levels of  agreement between proxy and patient, issues of  vulnerability 
and coercion in the families of  hospice and palliative care patients, and factors influencing 
the proxy's decision for the patient's participation. Because proxy information can be so 
useful in research involving hospice and palliative care patients, more research is needed to 
ensure when proxy-provided information is reliable and when it should not be depended on. 
While McPherson and Addington-Hall (2003) discussed this topic in their article, more 
research is needed to ensure when proxy-provided information is valid and can be used 
appropriately in research. 
The Effects of  Assistance on Disclosure  
 As many patients can be expected to need assistance completing research measures 
(Jordhøy et al., 1999), more empirical research is needed to clarify if  and when assistance 
influences participant disclosure in research. While it may not be feasible to deny assistance 
to participants, research in this area will allow for researchers to better understand how 
assistance may affect the information gathered and to hypothesize how assistance may have 
influenced the research findings. 
Summary 
 Aside from the many areas discussed in the literature review of  this thesis, 
researchers should also consider how they will deal with the possibility of  abuse reporting 
 63 
and using statistics appropriate for small sample sizes. Researchers should also be aware of  
the current areas of  controversy, including whether it is ethical to include or exclude hospice 
and palliative care patients as research participants and how best to minimizing inappropriate 
gate-keeping. Several challenging areas of  research in this population still need further 
clarification, both empirically and by published accounts of  researchers' experiences. Such 
areas include how to increase the inclusion of  diverse populations, the role of  coercion in 
the consent process, issues involving proxy consent and proxy-provided information, and the 
effects of  assistance on participant disclosure. 
 While conducting research with hospice and palliative care patients is often difficult, 
it is not impossible. Taking time early in the research process to anticipate potential 
challenges and choose the best possible methods of  working around them will result in more 
fruitful, valid research in this population. However, researchers new to this area can benefit 
greatly from the experience of  others in the field. The literature is rich in accounts of  
successes and shortfalls, and much is to be gained from the experiences and suggestions of  
researchers experienced with this population. Similarly, researchers should be aware that their 
accounts of  problems and successes when working in this population can be invaluable in 
informing others and increasing the quality of  later work. Lastly, although research in this 
population can be challenging, it is important to increase the quality of  life, quality of  care, 
and understanding of  individuals at the end of  life. Much remains to be gained in this area, 
despite the challenges.
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